Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Entasis Therapeutics Holdings Inc. (ETTX)

2.64   0.11 (4.35%) 01-17 17:24
Open: 2.59 Pre. Close: 2.53
High: 2.75 Low: 2.52
Volume: 854,424 Market Cap: 94M
Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Waltham, Massachusetts and currently employs 33 full-time employees. The firm is focused on the discovery, development and commercialization of antibacterial products to treat infections caused by multi-drug resistant Gram-negative bacteria. Its lead product candidate ETX2514 and its other product candidate ETX0282 inhibits bacterial resistance, b-lactamase enzyme. Its pipeline includes ETX2514UL, ETX0282CPDp, Zoliflodacin, and non-beta (b)-lactam inhibitors of the penicillin-binding proteins (NBP) Program. ETX2514SUL is a fixed-dose combination of ETX2514 with sulbactam, as a novel IV antibiotic with broad spectrum b-lactamase coverage. Zoliflodacin as a single dose, oral antibiotic monotherapy. ETX0282CPDP is an oral fixed-dose combination of ETX0282 with cefpodoxime proxetil. The firm is developing a class of antibiotics with its NBP program in which it is designing molecules for optimal activity against the penicillin-binding proteins (PBP) enzymes.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.755 - 2.768 2.768 - 2.78
Low: 2.489 - 2.504 2.504 - 2.517
Close: 2.615 - 2.64 2.64 - 2.662

Technical analysis

as of: 2021-01-15 4:40:08 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 3.42     One year: 4.00
Support: Support1: 2.21    Support2: 1.76
Resistance: Resistance1: 2.93    Resistance2: 3.42
Pivot: 2.52
Moving Average: MA(5): 2.50     MA(20): 2.52
MA(100): 2.20     MA(250): 2.89
MACD: MACD(12,26): 0.12     Signal(9): 0.14
Stochastic oscillator: %K(14,3): 50.78     %D(3): 45.61
RSI: RSI(14): 60.64
52-week: High: 5.64  Low: 1.58  Change(%): -45.9
Average Vol(K): 3-Month: 75820  10-Days: 42278

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ETTX has closed below upper band by 26.4%. Bollinger Bands are 16.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 15 Jan 2021
Where Does Wall Street Think Entasis Therapeutics Holdings Inc (ETTX) Stock Will Go? - InvestorsObserver

Thu, 07 Jan 2021
Entasis Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference - Yahoo Finance

Tue, 29 Dec 2020
Is Entasis Therapeutics Holdings Inc (ETTX) a Stock to Watch This Week? - InvestorsObserver

Mon, 14 Dec 2020
Should Entasis Therapeutics Holdings Inc (ETTX) Stock be in Your Portfolio? - InvestorsObserver

Thu, 05 Nov 2020
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update - GlobeNewswire

Wed, 28 Oct 2020
Do Analysts Agree on Entasis Therapeutics Holdings Inc (ETTX) Stock's Target Price? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 11
% Held by Insiders 58.86
% Held by Institutions 30.95
Shares Short (K) 207
Shares Short P. Month (K) 97

Stock Financials

EPS -2.922
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.750
Profit Margin
Operating Margin
Return on Assets (ttm) -52.5
Return on Equity (ttm) -91.9
Qtrly Rev. Growth
Gross Profit (p.s.) 0.197
Sales Per Share
EBITDA (p.s.) -1.574
Qtrly Earnings Growth
Operating Cash Flow (M) -46
Levered Free Cash Flow (M) -27

Stock Valuations

PE Ratio -0.90
PEG Ratio
Price to Book value 1.51
Price to Sales
Price to Cash Flow -2.05

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.